LTRN

LTRN

USD

Lantern Pharma Inc. Common Stock

$3.420+0.160 (4.908%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$3.260

高値

$3.510

安値

$3.020

出来高

0.09M

企業ファンダメンタルズ

時価総額

36.9M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.13M

取引所

NCM

通貨

USD

52週レンジ

安値 $2.55現在値 $3.420高値 $6.118

関連ニュース

BusinessWire

Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, will both be

もっと見る
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
BusinessWire

Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.

AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action. A novel differentiated

もっと見る
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
BusinessWire

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025

Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today

もっと見る
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。